Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT00900185
NCT00900185CompletedNot Applicable

Retrospective Analysis of Endostatin Genotype in Prostate Cancer Patients to Assess the Association of a Single Nucleotide Polymorphism (D104N) in Endostatin and Prostate Cancer

National Cancer Institute (NCI)0 sites750 target enrollmentStarted: May 12, 2009Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
750
Primary Endpoint
Frequency of D104N COL18A1 polymorphism in patients with prostate cancer and in healthy participants
Study OverviewEligibility CriteriaOutcomesInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

RATIONALE: Studying samples of blood from patients with cancer and from healthy participants in the laboratory may help doctors learn more about changes that may occur in DNA.

PURPOSE: This laboratory study is looking at blood samples from patients with prostate cancer and from healthy participants to identify a polymorphism that may help in the study of prostate cancer.

Detailed Description

OBJECTIVES:

Primary

  • Determine the incidence of the D104N COL18A1 polymorphism in patients with prostate cancer.

Secondary

  • Determine the incidence of this polymorphism in African-American patients with prostate cancer.

Study Design

Study Type
Observational

Eligibility Criteria

Sex
Male
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Frequency of D104N COL18A1 polymorphism in patients with prostate cancer and in healthy participants

Secondary Outcomes

  • Frequency of D104N COL18A1 polymorphism in African-American patients with prostate cancer and in healthy participants

Investigators

Sponsor Class
Nih

Similar Trials

Unknown
Not Applicable
Study of Biomarkers in Blood and/or Tumor Tissue Samples From Patients With Ductal Carcinoma in Situ and From Healthy VolunteersBreast Cancer
NCT00935233Queen Mary University of London6,000
Completed
Not Applicable
Study of Tissue and Blood Samples From Patients With Recurrent Prostate Cancer Who Received Lapatinib on Clinical Trial ECOG-E5803Prostate Cancer
NCT00897351ECOG-ACRIN Cancer Research Group37
Recruiting
Not Applicable
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic AnalysisBreast CancerLymphomaProstate CancerLung CancerOvarian Cancer
NCT01441089National Cancer Institute (NCI)1,100
Completed
Not Applicable
Biomarkers in Tissue and Blood Samples From Patients With Early-Stage Non-Small Cell Lung CancerLung Cancer
NCT01139944Alliance for Clinical Trials in Oncology99
Unknown
Not Applicable
Genes That Affect Disease Outcome in Patients With Metastatic Colorectal CancerColorectal Cancer
NCT00467129University of Sheffield800